Category Archives: In the Pipeline

“The Best Drug Companies Of The Past 15 Years?”

Matt Herper in Forbes’ “the Medicine Show” posts a point of view by Bernard Munos on what firms have done best in terms of approved drugs since 1995.  The link is here (http://onforb.es/zb6xgu), as are my comments on this provocative topic.  … Continue reading

Posted in Core Learnings, Financial, In the Pipeline | 1 Comment

 

Share

The R&D Returns “Ceiling”

BioPharma firms vary greatly in their ability to bring novel therapies to market – what causes some to underperform? Continue reading

Posted in General Interest, In the Pipeline | Tagged , , , | 3 Comments

 

Share